1. Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108.
2. Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics. 2014;9(1):3-12.
3. Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307.
4. Cruz JA, Westhof E. The Dynamic Landscapes of RNA Architecture. Cell. 2009;136(4):604– 609.
5. Rizvi NF, Smith GF. RNA as a small molecule druggable target. Bioorganic Med Chem Lett. 2017;27(23):5083–5088.
6. Howe JA, Wang H, Fischmann TO, et al. Selective small-molecule inhibition of an RNA structural element. Nature. 2015;526(7575):672-677.
7. Rizvi NF, Howe JA, Nahvi A, et al. Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry. ACS Chem Biol. 2018;13(3):820–831.
8. FDA Approves Oral Treatment for Spinal Muscular Atrophy, https://www.fda.gov/news- events/press-announcements/fda-approves-oral-treatment-spinal-muscular-atrophy, accessed August 7, 2020.
9. Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21−37.
10. Bartel DP. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell. 2004;116(2):281−297.
11. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet. 2008;9(2):102−114.
12. miRBase, http://www.mirbase.org.
13. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–874.
14. Van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11(9):644–656.
15. Chong MMW, Zhang G, Cheloufi S, Neubert TA, Hannon GJ, Littman DR. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev. 2010;24(17):1951−1960.
16. Song MS, Rossi JJ. Molecular mechanisms of Dicer: Endonuclease and enzymatic activity. Biochem J. 2017;474(10):1603−1618.
17. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.
18. Murata A, Otabe T, Zhang J, Nakatani K. BzDANP, a Small-Molecule Modulator of Pre-miR- 29a Maturation by Dicer. ACS Chem Biol. 2016;11(10):2790–2796.
19. Velagapudi SP, Gallo SM, Disney MD. Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat Chem Biol. 2014;10(4):291–297.
20. Costales MG, Haga CL, Velagapudi SP, Childs-Disney JL, Phinney DG, Disney MD. Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit. J Am Chem Soc. 2017;139(9):3446–3455.
21. Yan H, Bhattarai U, Guo ZF, Liang F Sen. Regulating miRNA-21 Biogenesis by Bifunctional Small Molecules. J Am Chem Soc. 2017;139(14):4987-4990. 2
22. Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS. Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays. ACS Chem Biol. 2017;12(2):435- 443.
23. Murata A, Mori Y, Di Y, Sugai A, Das B, Takashima Y, Nakatani K. Small Molecule-Induced Dimerization of Hairpin RNA Interfered with the Dicer Cleavage Reaction. Biochemistry. 2021;60(4) :245–249
24. Murata A, Fukuzumi T, Umemoto S, Nakatani K. Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: Targeting secondary structures of pre-miRNA by small molecules. Bioorganic Med Chem Lett. 2013;23(1):252–255.
25. Murata A, Harada Y, Fukuzumi T, Nakatani K. Fluorescent indicator displacement assay of ligands targeting 10 microRNA precursors. Bioorganic Med Chem. 2013;21(22):7101–7106.
26. Fukuzumi T, Murata A, Aikawa H, Harada Y, Nakatani K. Exploratory Study on the RNA- Binding Structural Motifs by Library Screening Targeting pre-miRNA-29 a. Chem - A Eur J. 2015;21(47): 16859–16867.
27. Otabe T, Nagano K, Kawai G, Murata A, Nakatani K. Inhibition of pre-miRNA-136 processing by Dicer with small molecule BzDANP suggested the formation of ternary complex of pre-miR- 136–BzDANP–Dicer. Bioorganic Med Chem. 2019;27(10):2140–2148.
28. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346(6287):818–822.
29. Oliphant AR, Brandl CJ, Struhl K. Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein. Mol Cell Biol. 1989;9(7):2944–2949.
30. Wilson DS, Szostak JW. In vitro selection of functional nucleic acids. Annu Rev Biochem. 1999;68:611–647.
31. J Sztuba-Solinska J, Shenoy SR, Gareiss P, et al. Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays. J Am Chem Soc. 2014;136(23):8402–8410
32. Yu AM, Choi YH, Tu MJ. RNA drugs and RNA targets for small molecules: Principles, progress, and challenges. Pharmacol Rev. 2020;72(4):862–898.
33. Starega-Roslan J, Galka-Marciniak P, Krzyzosiak WJ. Nucleotide sequence of miRNA precursor contributes to cleavage site selection by Dicer. Nucleic Acids Res. 2015;43(22):10939–10951
34. Liu Z, Wang J, Cheng H, et al. Cryo-EM Structure of Human Dicer and Its Complexes with a Pre-miRNA Substrate. Cell. 2018;173(5):1191–1203.